Jim Cramer Gives His Opinion On Opko Health, Edwards Lifesciences And GW Pharma

On CNBC's Mad Money, Jim Cramer spoke about Opko Health Inc. OPK. He has faith in its CEO, Phillip Frost, and he wants to take a long-term view in the stock. Opko Health spiked 9.84 percent on Monday.

Cramer explained that Edwards Lifesciences Corp EW has been hit by a lot of negative news and the latest is that its death risk increased and that there are less sick patients. He believes the stock is good and he likes it, but he recognizes the fact that the pressure in the healthcare sector is so big that he wants to avoid it. He would wait for the stock to settle after the recent sell off, before buying more.

GW Pharmaceuticals PLC- ADR GWPH is a winner, but Cramer wouldn't be too aggressive with the stock.